Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific antigen level alone (Q35924515)

From Wikidata

Jump to navigation Jump to search

scientific article published on 24 October 2008

Language	Label	Description	Also known as
English	Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific antigen level alone	scientific article published on 24 October 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific antigen level alone (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

logistic regression model

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

8

object named as

Alan W Partin

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

5

object named as

Samir S Taneja

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

author name string

David J Hernandez

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Misop Han

2

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Elizabeth B Humphreys

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Leslie A Mangold

4

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Stacy J Childs

6

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Georg Bartsch

7

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

publication date

24 October 2008

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

BJU International

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

103

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

609-614

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Development and external validation of an extended repeat biopsy nomogram

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340925

2 October 2017

External validation of the Prostate Cancer Prevention Trial risk calculator in a screened population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340925

2 October 2017

Development and external validation of an extended 10-core biopsy nomogram

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340925

2 October 2017

African-American race is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340925

2 October 2017

Initial biopsy outcome prediction--head-to-head comparison of a logistic regression-based nomogram versus artificial neural network.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340925

2 October 2017

Nomogram prediction for prostate cancer and aggressive prostate cancer at time of biopsy: utilizing all risk factors and tumor markers for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340925

2 October 2017

Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340925

2 October 2017

Development of a nomogram to predict probability of positive initial prostate biopsy among Japanese patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340925

2 October 2017

Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340925

2 October 2017

Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340925

2 October 2017

Validation of a nomogram for predicting positive repeat biopsy for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340925

2 October 2017

Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate specific antigen levels ≤ 10 ng/mL

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340925

2 October 2017

A Nomogram For Predicting a Positive Repeat Prostate Biopsy in Patients With a Previous Negative Biopsy Session

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340925

2 October 2017

The influence of finasteride on the development of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340925

2 October 2017

Multicenter evaluation of an artificial neural network to increase the prostate cancer detection rate and reduce unnecessary biopsies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340925

2 October 2017

Comparisons of nomograms and urologists' predictions in prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340925

2 October 2017

Novel artificial neural network for early detection of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340925

2 October 2017

Age, prostate-specific antigen, and digital rectal examination as determinants of the probability of having prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340925

2 October 2017

Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340925

2 October 2017

Development of a decision-making tool to predict risk of prostate cancer: the Cancer of the Prostate Risk Index (CAPRI) test.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340925

2 October 2017

Multicenter comparison of the diagnostic performance of free prostate-specific antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340925

2 October 2017

An algorithm combining age, total prostate-specific antigen (PSA), and percent free PSA to predict prostate cancer: results on 4298 cases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340925

11 July 2018

Complexed Prostate Specific Antigen Improves Specificity for Prostate Cancer Detection: Results of a Prospective Multicenter Clinical Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340925

24 September 2018

Incidence and clinical significance of false-negative sextant prostate biopsies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3340925

24 September 2018

Predictors of prostate cancer after initial negative systematic 12 core biopsy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19007374

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PSA velocity for the diagnosis of early prostate cancer. A new concept

1 reference

https://pubmed.ncbi.nlm.nih.gov/19007374

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate rebiopsy is a poor surrogate of treatment efficacy in localized prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19007374

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate cancer nomograms: an update

1 reference

https://pubmed.ncbi.nlm.nih.gov/19007374

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1464-410X.2008.08127.X

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35924515&oldid=1856112960"